top of page
CoRegen Final Logo-03.png
iStock-520835310.jpg

The CoRegen Team: Pioneers in Science and Innovation

At CoRegen, we are driven by a team of world-renowned scientists, biotech innovators, and industry leaders dedicated to transforming the future of medicine. With expertise spanning molecular endocrinology, regenerative medicine, immunotherapy, and pharmaceutical development, our team is at the forefront of groundbreaking discoveries. Their collective work has shaped major advancements in cancer treatment, precision medicine, and beyond. Meet the brilliant minds behind our mission to redefine what’s possible in patient care.

Management and Board of Directors

Bert W O'Malley, MD
Inventor & Principal Scientist, Board Member

3.png

  • Chancellor of Baylor College of Medicine

  • Elected to the National Academies of Sciences, Medicine, and Inventors.

  • 50+ years of expertise

  • "Father of Molecular Endocrinology"

  • Recipient of 65+ major honors and awards, including the National Medal of Science 

  • Published over 750 scientific papers and holds 33 patents.

Steve Gorlin
Vice Chairman & President

2.png

  • 40+ years of pharma and biotech leadership

  • Six companies reached values or sold for $1B+

  • Notably, Medivation was acquired by Pfizer for $14.2B

Clifford Dacso, MD, MPH, MBA
Chief Medical Officer & Board Member

4.png

  • 40+ Years of Experience

  •  Professor of Molecular and Cellular Biology, Medicine and Dermatology

  • Chair for institutional review board of nationwide cancer practice

David Lonard, PhD
Chief Science Officer

1.png

  • 30+ Years of Experience

  • Professor of Molecular and Cell Biology and Molecular Biology at Baylor College of Medicine

  • Developed Strategies for Regulating Molecular Processes

Sang Jun Han, PhD
Director of Laboratory Research

12.png

  • 30+ Years of Research Experience

  • Richard E. Buller Professor, Department of Molecular and Cellular Biology, Baylor College of Medicine

  • Expert in Animal Genetics and Preclinical Animal Model Development

Lisa McClendon
Chief Science Officer Molecular & Cellular Biology

lisa.jpg

  • 30+ Years of Experience

  • Associate Professor of Molecular and Cellular Biology and Dermatology at Baylor College of Medicine

  • Created Strategies for Tissue Healing at the Molecular Level

Jonathan W. Simons, MD
Board Member

14.png

  • Chief Science Officer and Medical Director of the Marcus Foundation

  • Senior Fellow with the Milken Institute

  • Board of Directors member of FasterCures

  • Former President and CEO of the Prostate Cancer Foundation

  • Board of Directors Melanoma Research Alliance and Prostate Cancer Foundation

  • Scientific Advisory Committee V Foundation 

John Thomas
CFO, Treasurer & Corporate Secretary

9.png

  • 45+ years of experience in public and private sector finance

  • Served as CFO for CytRx, Medicis, EntreMed, ClearPoint, DARA BioSciences Companies

William Haseltine, PhD
Board Member

10.png

  • 40+ years of experience

  • Known for his pioneering work on cancer, HIV/AIDS, and genomics

  • Professor at Harvard Medical School

  • Co-founder Human Genome Sciences

Lee Fleisher, MD, ML
Board Member

13.png

  • Emeritus Professor and Former Chair of Anesthesiology at the University of Pennsylvania

  • Former CMO and Director of the Center for Clinical Standards at the Centers for Medicare & Medicaid Services (CMS)

  • Senior Advisor, Milken FasterCures and BiPartisan Policy Center

  • Author of over 400+ original publications

  • Member of the National Academy of Medicine 

Edward J. Benz Jr., MD
Board Member

11.png

  • Former President and CEO of Dana-Farber Cancer Institute and American Society of Hematology

  • Former Chairperson and Physician in Chief at Johns Hopkins University

  • Associate editor of the New England Journal of Medicine

Scientific and Clinical Advisors

Robert Langer, SCD
Chairman Scientific Advisory Board

6.png

  • Institute Professor at MIT, the highest honor for faculty. 1600 articles and cited over 442,000 times 

  • Co-founder of companies including Moderna; patents licensed or sublicensed over 400 companies.

  • Recipient of over 220 awards

David J. Kerr, CBE, MA, MD, DSC, FRCP, FRCGP, FMEDSCI | Advisory Board Member

18.png

  • Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics

  • Head of Pharmacology at the University of Oxford

  • Appointed Commander of the British Empire (CBE) by Her Majesty Queen Elizabeth II 

  • Awarded the China Friendship Medal, their highest civilian honor by President Xi Jinping 

Roy S. Herbst, MD, PhD
Advisory Board Member

16.png

  • Deputy Director for Clinical Affairs & Chief of Medical Oncology for Yale Cancer Center and Smilow Cancer Hospital

  • Ensign Professor of Medicine & Assistant Dean for Translational Research at Yale School of Medicine

Richard Heyman, PhD
Scientific and Clinical Advisor

17.png

  • Founder Metacrine, Inc., Seragon Pharmaceuticals, Aragon Pharmaceuticals, and X-Ceptor Therapeutics

  • Board of Trustees Member, Salk Institute for Biological Studies

  • Author or inventor on 120+ publications and patents

Stanley H Appel, MD
Scientific and Clinical Advisor

7.png

  • Director, Ann Kimball & John W. Johnson Center for Cellular Therapeutics and MDA/ALSA ALS Research and Clinical Center

  • 15 published books and 350+ articles

  • Named 2008 Best of the Best Physicians by the Medical Journal Houston

Donald P. McDonnell,
PhD Scientific and Clinical Advisor

19.png

  • Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, Duke University School of Medicine; Professor of Pharmacology and Cancer Biology, and Cell Biology

  • Member of the Duke Cancer Institute 300+ publications and 80+ grants awarded

Scott A. Levitt, BS
Advisory Board Member

8.png

  • 10+ years experience in healthcare finance focused biotechnology, pharmaceuticals, medical devices, life science tools, and diagnostics

  • Vice President at Pharmakon Advisors, the largest life science debt investor with >$6B across 45+ companies

Mark K. Siegal, MD, FACP
Advisory Board Member

15.png

  • Clinical Professor of Medicine at NYU Langone Health

  • Medical Director of Doctor Radio

  • Fox News Medical Analyst

Emeritus

Michael Dey, PhD (1951-2025)
Emeritus Scientific and Clinical Advisor  

20.png

  • Former President Scientific Affairs for Wyeth's Women's Health Care

  • Former President for Wyeth's Women's Health Care Division, with $3+ billion annual sales

  • 40+ years experience in Pharmacology & Toxicology

Frank Prendergrast, MD, PhD (1945-2023)
Emeritus Board Member

franklyn.png

  • Renowned physician-scientist with decades of impact in medicine and research

  • Rhodes Scholar; PhD in biochemistry from Mayo Clinic/University of Minnesota

  • Held leadership roles at Mayo Clinic, including Director of Research and Cancer Center

Franklyn Letter.png
bottom of page